Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

39 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

NCT06841354

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • USA Mitchell Cancer Institute ( Site 0090) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers ( Site 0036) Chandler, Arizona, United States
  • City of Hope ( Site 0097) Duarte, California, United States
  • City of Hope Lennar Foundation Cancer Center ( Site 0099) Irvine, California, United States
View all 267 locations
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

NCT06966700

Conditions
Breast Diseases, Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, +6 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0066) Gilbert, Arizona, United States
  • Mayo Clinic Cancer Center ( Site 0034) Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0035) Tucson, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center ( Site 0055) Burbank, California, United States
View all 317 locations
View Trial Details
Recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT05208762

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 62 locations
View Trial Details
Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

NCT04895709

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +56 more
Locations
  • Community Cancer Institute Clovis, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of Iowa Iowa City, Iowa, United States
View all 47 locations
View Trial Details
Recruiting

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 23 locations
View Trial Details
Recruiting

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

NCT06246968

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816

Conditions
Adnexal Diseases, Advanced Solid Tumours, Breast Diseases, +53 more
Locations
  • Guy's Hopsital London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, United Kingdom
View Trial Details
Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT06586957

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations
  • University of Arkansas Medical School Little Rock, Arkansas, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
View all 19 locations
View Trial Details
Recruiting

Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery

NCT05973864

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • CHU Amiens Picardie_Site Sud Amiens, France
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Jean Minoz Besançon, France
View all 20 locations
View Trial Details

Related conditions